Expression and significance of p53 and mdm2 in atypical intestinal metaplasia and gastric carcinoma

Oncology Letters

Volumn 2, Issue 4, 2011, Pages 707-712

  Wang, Lin ^a,b   Zhang, Xiao Ying ^a   Xu, Ling ^a   Liu, Wen Jun ^a   Zhang, Juan ^b   Zhang, Jian Ping ^a,b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Atypical intestinal metaplasia; Murine double minute gene 2; Simple intestinal metaplasia

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENDOSCOPIC BIOPSY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; STOMACH CARCINOMA; STOMACH MUCOSA;

EID: 79958055786     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2011.292     Document Type: Article

References (37)

1. Burkitt MD, Varro A and Pritchard DM: Importance of gastrin in the pathogenesis and treatment of gastric tumors. World J Gastroenterol 15: 1-16, 2009.
2. Chen XM, Chen GY, Wang ZR, Zhu FS, Wang XL and Zhang X: Detection of micrometastasis of gastric carcinoma in peripheral blood circulation. World J Gastroenterol 10: 804-808, 2004.
3. Nakajima N, Ito Y, Yokoyama K, Uno A, Kinukawa N, Nemoto N and Moriyama M: The expression of murine double minute 2 (MDM2) on helicobacter pylori-infected intestinal metaplasia and gastric cancer. J Clin Biochem Nutr 44: 196-202, 2009.
4. Leung WK and Sung JJ: Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther 16: 1209-1216, 2002.
5. Jass JR: Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol 33: 801-881, 1980.
6. Jass JR and Filipe MI: A variant intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology 3: 191-199, 1979.
7. Dixon MF: Campylobacter and chronic gastritis. In: Campylobacter and Gastroduodenal Disease. Rathbone BJ, Heatley RV (eds). Blackwell Scientific Publications, Oxford, pp1061-1116, 1989.
8. Sipponen P and Hyvainen H: Role of helicobacter pylori in the pathogenesis of gastric peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl 196: 3-6, 1993.
9. Dixon MF: Pathophysiology of helicobacter pylori infection. Scand J Gastroenterol Suppl 201: 7-10, 1994.
10. Rothery GA and Day DW: Intestinal metaplasia in endoscopic biopsy specimens of gastric mucosa. J Clin Pathol 38: 613-621, 1985.
11. Ectors N and Dixon MF: The prognostic value of sulphomucin positive intestinal metaplasia in the development of gastric cancer. Histopathology 10: 1271-1277, 1986.
12. Petersson F, Borch K and Franzén LE: Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis. Scand J Gastroenterol 37: 262-266, 2002.
13. Zheng Y, Wang L, Zhang JP, Yang JY, Zhao ZM and Zhang XY: Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma. World J Gastroenterol 16: 339-344, 2010.
14. Barak Y, Juven T, Haffner R, and Oren M: mdm2 expression is induced by wild type p53 activity. EMBO J 12: 461-468, 1993.
15. Momand J and Zambetti GP: Mdm-2: 'big brother' of p53. J Cell Biochem 64: 343-352, 1997.
16. Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ and Oren M: Generation of oscillations by the p53-Mdm2 feedback loop: a theoretical and experimental study. Proc Natl Acad Sci USA 97: 11250-11255, 2000.
17. Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S, Hill DE, Sidransky D, Kinzler KW and Vogelstein B: p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 53: 2231-2234, 1993.
18. Leite KR, Franco MF, Srougi M, Nesrallah LJ, Nesrallah A, Bevilacqua RG, Darini E, Carvalho CM, Meirelles MI, Santana I and Camara-Lopes LH: Abnormal expression of MDM2 in prostate carcinoma. Mod. Pathol 14: 428-436, 2001.
19. Reis CA, David L, Nielsen PA, Clausen H, Mirgorodskaya K, Roepstorff P and Sobrinho-Simões M: Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody. Int J Cancer 74: 112-121, 1997.
20. Jass JR and Filipe MI: The mucin profile of normal gastric epithelium, intestinal metaplasia and gastric carcinoma. Histochem J 13: 831-939, 1981.
21. Hwang JH: To perform a biopsy or not to perform a biopsy? Does confocal endomicroscopy provide the answer for surveillance in Barrett's esophagus? Gastrointest Endosc 70: 655-657, 2009.
22. Liu H, Li YQ, Yu T, Zhao YA, Zhang JP, Zhang JN, Guo YT, Xie XJ, Zhang TG and Desmond PV: Confocal endomicroscopy for in vivo detection of microvascular architecture in normal and malignant lesions of upper gastrointestinal tract. J Gastroenterol Hepatol 23: 56-61, 2008.
23. Vogelstein B and Kinzler KW: p53 function and dysfunction. Cell 70: 523-526, 1992.
24. Harris AL: Mutant p53 - the commonest genetic abnormality in human cancer? J Pathol 162: 5-6, 1990.
25. Correa P and Shiao YH: Phenotypic and genotypic events in gastric carcinogenesis. Cancer Res 54: 1941-1943, 1994.
26. Tahara E, Kuniyasu H, Yasui W and Yokozaki H: Gene alterations in intestinal metaplasia and gastric cancer. Eur J Gastroenterol Hepatol 6: 97-101, 1994.
27. Shiao YH, Ruqqe M, Correa P, Lehmann HP, and Scheer WD: p53 alteration in gastric precancerous lesions. Am J Pathol 144: 511-517, 1994.
28. Uchino S, Noguchi M, Ochiai A, Saito T, Kobayashi M, and Hirohashi S: p53 mutation in gastric cancer: a genetic model for carcinogenesis is common to gastric and colorectal cancer. Int J Cancer 54: 759-764, 1993.
29. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Sakata K, Kashiwaba M and Satodate R: The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 176: 249-258, 1995.
30. Tamura G, Sato K, Akiyama S, Tsuchiya T, Endoh Y, Usuba O, Kimura W, Nishizuka S and Motoyama T: Molecular characterization of undifferentiated-type gastric carcinoma. Lab Invest 81: 593-598, 2001.
31. Ranzani GN, Luinetti O, Padovan LS, Calistri D, Renault B, Burrel M, Amadori D, Fiocca R, and Solcia E: p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type. Cancer Epidemiol Biomarkers Prev 4: 223-231, 1995.
32. Ochiai A, Yamauchi Y, and Hirohashi S: p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia. Int J Cancer 69: 28-33, 1996.
33. Oliner JD, Kinzler KW, Meltzer PS, George DL and Vogelstein B: Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358: 80-83, 1992.
34. Bueso-Ramos CE, Manshouri T, Haidar MA, Huh YO, Keating MJ and Albitar M: Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosis. Leuk Lymphoma 17: 13-18, 1995.
35. Iwakuma T and Lozano G: MDM2, an introduction. Mol Cancer Res 1: 993-1000, 2003.
36. Günther T, Schneider-Stock R, Häckel C, Kasper HU, Pross M, Hackelsberger A, Lippert H and Roessner A: Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations. Mod Pathol 13: 621-626, 2000.
37. Tanière P, Martel-Planche G, Maurici D, Lombard-Bohas C, Scoazec JY, Montesano R, Berger F and Hainaut P: Molecular and clinical differences between adenocarcinomas of the esophagus and of the gastric cardia. Am J Pathol 158: 33-40, 2001.